Placebo (N = 35) N (%) or Mean (SD) | Omega-3 (N = 27) N (%) or Mean (SD) | Overall (N = 62) N (%) or Mean (SD) | ||
---|---|---|---|---|
Age (years) | 60.2 (10.8) | 62.3 (9.7) | 61.1 (10.3) | |
Female Gender | 22 (63 %) | 18 (67 %) | 40 (65 %) | |
Race/ethnicity | Non-Latino White | 7 (20 %) | 11 (41 %) | 18 (29 %) |
Latino | 28 (80 %) | 16 (59 %) | 44 (71 %) | |
Educational Status | Did Not Complete High School | 18 (51 %) | 10 (37 %) | 28 (45 %) |
Completed High School | 9 (26 %) | 10 (37 %) | 19 (31 %) | |
Completed College | 8 (23 %) | 7 (26 %) | 15 (24 %) | |
Unemployed | 28 (80 %) | 21 (81 %) | 49 (80 %) | |
Body Mass Index (kg/m2) | 31.5 (7.1) | 33.9 (8.6) | 32.6 (7.8) | |
Systolic Blood Pressure (mm Hg)a | 137 (16) | 128 (14) | 133 (16) | |
Diastolic Blood Pressure (mm Hg) | 82 (9) | 78 (10) | 81 (10) | |
Antihypertensive Medication | 32 (91 %) | 21 (78 %) | 53 (85 %) | |
Statin therapy | 17 (49 %) | 11 (41 %) | 28 (45 %) | |
Total cholesterol (mg/dL) | 179 (43) | 179 (38) | 179 (40) | |
Triglycerides (mg/dL) | 188 (103) | 173 (65) | 182 (89) | |
HDL-C (mg/dL) | 48.4 (14.9) | 44.9 (12.4) | 46.9 (13.9) | |
LDL-C (mg/dL) | 97 (38) | 99 (29) | 98 (34) | |
Diabetes diagnosis | 19 (54 %) | 12 (48 %) | 31 (52 %) | |
Hemoglobin A1c (%) | 6.7 (1.8) | 6.3 (1.3) | 6.6 (1.6) | |
Glucose (mg/dL) | 127 (61) | 111 (25) | 120 (49) | |
Smoking status | Current | 12 (34 %) | 6 (22 %) | 18 (29 %) |
Former | 23 (66 %) | 21 (78 %) | 44 (71 %) | |
hsCRP (mg/L) | 3.42 (3.35) | 5.63 (5.05) | 4.38 (4.29) | |
Adiponectin (ug/mL) | 10.6 (8.3) | 12.2 (7.8) | 11.4 (8.1) | |
LpPLA2 mass (ng/mL) | 244 (46) | 252 (62) | 247 (53) | |
Mean PWV (cm/s) | 1690 (335) | 1602 (324) | 1652 (330) |